FDA Recommends Monovalent XBB.1.5 Vaccine for Fall 2023
Based on the current and expected evolution of SARS-CoV-2, the FDA Vaccines and Related Biological Products Advisory Committee (VRBPAC) is advising vaccine manufacturers to update
Based on the current and expected evolution of SARS-CoV-2, the FDA Vaccines and Related Biological Products Advisory Committee (VRBPAC) is advising vaccine manufacturers to update
As noted in our Key Points this week, Australia has seen a significant uptick in COVID-19 and flu hospitalizations in recent weeks. As we’ve discussed
A new COVID Omicron subvariant (XBB.1.16, known as “Arcturus”) has been making headlines recently for being highly contagious and causing conjunctivitis (pink eye). As discussed
A new Government Accountability Office (GAO) report has noted a critical need to address deficiencies at the Department of Health and Human Services (HHS) that “impaired
With the US declaring an end to the COVID-19 public health emergency (PHE) as of May 11, 2023, CDC has updated its guidance to incorporate
On Tuesday, April 18, FDA rescinded authorization for the original monovalent COVID vaccines, instead authorizing the current bivalent vaccines (original and Omicron BA.4/BA.5 strains) to
Two emerging infectious diseases have been in the news in recent weeks. While both have some potential for infecting workers, Marburg is primarily being seen
In September 2020, CDC launched a National Wastewater Surveillance System (NWSS) to help track the presence of SARS-CoV-2, the virus that causes COVID-19. But it
The summary of the NYT article entitled The Next Pandemic: Not if, but When stated “The new, aggressive pathogens in China and Saudi Arabia may
The US is currently seeing some very positive downward trends in the various infectious diseases that TAG has been tracking: While this does leave us